Effects of tiotropium and formoterol on quiet breathing pattern assessed by optoelectronic plethysmography in COPD patients: a pilot study

Effects of tiotropium and formoterol on quiet breathing pattern assessed by optoelectronic plethysmography in COPD patients: a pilot study

Introduction: Chronic obstructive pulmonary disease (COPD) is a disease characterized by an airflow limitation that is not fully reversible. β 2 -agonists and anticholinergics represent the most effective therapeutic options. Optoelectronic plethysmography (OEP) is a novel technology, which provides...

Full description

Bibliographic Details
Main Authors:	Roberto Walter Dal Negro, Claudio Turati, Claudio Micheletto, Francesco Menegoni
Format:	Article
Language:	English
Published:	SAGE Publishing 2012-04-01
Series:	Therapeutic Advances in Respiratory Disease
Online Access:	https://doi.org/10.1177/1753465811433579

Similar Items

Tiotropium in COPD: clinical outcomes and economic evidence
by: Orietta Zaniolo, et al.
Published: (2010-03-01)

Comparative effectiveness of budesonide/formoterol combination and tiotropium bromide among COPD patients new to these controller treatments
by: Trudo F, et al.
Published: (2015-09-01)

Clinical and pharmacoeconomic profile of COPD patients with FEV1 50—60% predicted: pilot study on the impact of the extended indication of ICS/LABA
by: Roberto Walter Dal Negro, et al.
Published: (2009-04-01)

Tidal breathing patterns derived from structured light plethysmography in COPD patients compared with healthy subjects
by: Motamedi-Fakhr S, et al.
Published: (2016-12-01)

Optoelectronic Plethysmography has Improved our Knowledge of Respiratory Physiology and Pathophysiology
by: Barbara Lanini, et al.
Published: (2008-12-01)

Efficacy of tiotropium in the prevention of exacerbations of COPD
by: Antonio Anzueto, et al.
Published: (2009-06-01)

Tiotropium as essential maintenance therapy in COPD
by: M. Decramer
Published: (2006-12-01)

Umeclidinium/Vilanterol Compared with Fluticasone Propionate/Salmeterol, Budesonide/Formoterol, and Tiotropium as Initial Maintenance Therapy in Patients with COPD Who Have High Costs and Comorbidities
by: Kalhan R, et al.
Published: (2021-04-01)

Tiotropium/olodaterol versus tiotropium in Japanese patients with COPD: results from the DYNAGITO study
by: Ichinose M, et al.
Published: (2018-07-01)

AMPLIFY: a randomized, Phase III study evaluating the efficacy and safety of aclidinium/formoterol vs monocomponents and tiotropium in patients with moderate-to-very severe symptomatic COPD
by: Sethi S, et al.
Published: (2019-03-01)

Nuclear HSP90 and HSP70 in COPD patients treated with formoterol or formoterol and corticosteroids
by: Holownia A, et al.
Published: (2009-12-01)

Tiotropium/olodaterol versus tiotropium in Japanese patients with COPD: results from the DYNAGITO study [Corrigendum]
by: Ichinose M, et al.
Published: (2018-10-01)

Real‑life cost and cost‑effectiveness for tiotropium 18 μg od monotherapy in moderate and severe COPD patients: a 48‑month survey
by: Massimiliano Povero, et al.
Published: (2014-06-01)

Automated Classification of Whole Body Plethysmography Waveforms to Quantify Breathing Patterns
by: Michael D. Sunshine, et al.
Published: (2021-08-01)

Reference equations for tidal breathing parameters using structured light plethysmography
by: Shayan Motamedi-Fakhr, et al.
Published: (2021-06-01)

Electromagnetic inductance plethysmography is well suited to measure tidal breathing in infants
by: Mariann H.L. Bentsen, et al.
Published: (2016-11-01)

Measuring Ventilatory Activity with Structured Light Plethysmography (SLP) Reduces Instrumental Observer Effect and Preserves Tidal Breathing Variability in Healthy and COPD
by: Marie-Cécile Niérat, et al.
Published: (2017-05-01)

Safety, tolerability and risk benefit analysis of tiotropium in COPD
by: Yuji Oba, et al.
Published: (2008-11-01)

Effect of add-on therapy of tiotropium in COPD treated with theophylline
by: Tomotaka Kawayama, et al.
Published: (2008-03-01)

The effect of tiotropium therapy on markers of elastin degradation in COPD
by: Tartell Lori, et al.
Published: (2009-02-01)

Socioeconomic gradients in tiotropium use among adults with COPD
by: Paul D Blanc, et al.
Published: (2008-10-01)

Budesonide/formoterol combination in COPD: a US perspective
by: Amir Sharafkhaneh, et al.
Published: (2010-10-01)

Breathomics for Assessing the Effects of Treatment and Withdrawal With Inhaled Beclomethasone/Formoterol in Patients With COPD
by: Paolo Montuschi, et al.
Published: (2018-04-01)

Total lung capacity by plethysmography and high-resolution computed tomography in COPD
by: Garfield JL, et al.
Published: (2012-02-01)

Quality of life and adherence to inhaled corticosteroids and tiotropium in COPD are related
by: Koehorst-ter Huurne K, et al.
Published: (2016-07-01)

Efficacy of tiotropium–olodaterol fixed-dose combination in COPD
by: Derom E, et al.
Published: (2016-12-01)

Pharmacologic rationale underlying the therapeutic effects of tiotropium/olodaterol in COPD
by: Pelaia G, et al.
Published: (2015-10-01)

Effects of indacaterol versus tiotropium on exercise tolerance in patients with moderate COPD: a pilot randomized crossover study
by: Danilo Cortozi Berton, et al.

Nebulized formoterol: a review of clinical efficacy and safety in COPD
by: Nicholas J Gross, et al.
Published: (2010-06-01)

New combinations in the treatment of COPD: rationale for aclidinium–formoterol
by: Incorvaia C, et al.
Published: (2016-02-01)

Tiotropium and exercise training in COPD patients: Effects on dyspnea and exercise tolerance
by: Nicolino Ambrosino, et al.
Published: (2008-10-01)

COPD patients responding to Tiotropium with dyspnea relief: a proof of efficacy?
by: Rossi, Stephanie
Published: (2009)

Erdosteine enhances airway response to salbutamol in patients with mild-to-moderate COPD
by: Roberto Dal Negro, et al.
Published: (2008-10-01)

The impact of LABA+ICS fixed combinations on morbidity and economic burden of COPD in Italy: a six-year observational study
by: Roberto Dal Negro, et al.
Published: (2011-04-01)

Early efficacy of budesonide/formoterol in patients with moderate-to-very-severe COPD
by: Calverley PM, et al.
Published: (2016-12-01)

Risks of budesonide/formoterol for the treatment of stable COPD: a meta-analysis
by: Tang B, et al.
Published: (2019-04-01)

Fluticasone propionate/formoterol for COPD management: a randomized controlled trial
by: Papi A, et al.
Published: (2017-07-01)

COST-EFFECTIVENESS OF VILANEROL / UMECLIDINIUM VERSUS TIOTROPIUM IN SEVERE AND VERY SEVERE COPD
by: E. G. Kosolapov, et al.
Published: (2017-08-01)

Tiotropium HandiHaler&reg; in the treatment of COPD: A safety review
by: Steven Kesten, et al.
Published: (2009-10-01)

Preventing and managing exacerbations in COPD &ndash; critical appraisal of the role of tiotropium
by: Donald P Tashkin
Published: (2010-02-01)